Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine

Ying Li1, Jing Gao2, Xubin Zheng3

  • 1The First Hospital of Lanzhou University, Lanzhou, China.

PubMed

Insights

This study developed a data-driven model for diagnosing portal vein thrombosis (PVT) in cirrhosis patients. The SVM-Naïve Bayes-QDA model accurately identifies PVT, improving clinical decisions for chronic liver disease.

Area of Science:

  • Hepatology
  • Medical Informatics
  • Machine Learning

Background:

  • Portal vein thrombosis (PVT) is a critical complication in patients with liver cirrhosis.
  • Early and accurate diagnosis of PVT is essential for effective patient management.
  • Chronic hepatitis liver cirrhosis patients are particularly susceptible to PVT.

Purpose of the Study:

  • To develop and validate a data-driven predictive model for diagnosing PVT in chronic liver cirrhosis patients.
  • To identify key clinical and laboratory features predictive of PVT.
  • To enhance diagnostic accuracy and clinical decision-making for PVT in this population.

Main Methods:

  • Utilized data from 816 chronic cirrhosis patients (Lanzhou and Jilin cohorts) for training and validation.
  • Employed a stacking ensemble approach combining Support Vector Machine (SVM), Naïve Bayes, and Quadratic Discriminant Analysis (QDA).
  • Identified seven shared predictive features: Portal Velocity (PV), Prothrombin Time (PT), Portal Vein Diameter (PVD), Prothrombin Time Activity (PTA), Activated Partial Thromboplastin Time (APTT), age, and Child-Pugh score (CPS).

Main Results:

  • The SVM and Naïve Bayes classifiers identified key features for PVT classification.
  • The QDA model, trained on seven shared features, showed significant differentiation between PVT and non-PVT cases (AUROC=0.73 in Lanzhou, 0.86 in Jilin).
  • The developed QDA model outperformed other machine learning methods in comparative analysis.

Conclusions:

  • A comprehensive data-driven model (SVM-Naïve Bayes-QDA) for PVT diagnosis in cirrhotic patients was successfully developed.
  • This model enhances clinical decision-making for managing PVT in patients with chronic liver disease.
  • The proposed model offers a precise approach to PVT management in the cirrhotic population.
Abstract

Related Concept Videos

Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...